CRDF
Cardiff Oncology Inc
1.10$
-6.1%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -23.7% | +39.8% | +7.3% | +20.9% | +50.0% | -45.9% | +11.7% | -21.0% | -11.7% | +107.7% | -14.8% | -62.5% | +79.1% | -26.5% | -36.8% | +216.3% | -12.3% | -39.6% | -5.6% | +26.5% | +54.7% | -44.4% | +23.0% | +2.2% | +37.6% | -35.2% | +30.1% | +30.6% | +10.6% | +31.4% | -20.5% | +1.2% | -8.5% | -27.8% | +11.0% | -0.8% | +102.5% | -83.1% | +153.7% | – | |
| – | +38.3% | +5.0% | -45.1% | +39.9% | -19.1% | -4.3% | -44.2% | -87.0% | +2,237,256.3% | -99.6% | +6.9% | -0.4% | +1.6% | -5.5% | -8.5% | +15.3% | +12.0% | +2.5% | +25.6% | +0.8% | -96.1% | -80.9% | +22.6% | +113.2% | -38.3% | +80.0% | +8.9% | +9.2% | -3.7% | -1.0% | +2.9% | +9,081.0% | -99.0% | – | – | – | – | -0.9% | – | – | |
| – | – | – | – | – | – | – | – | – | -967,581.9% | – | – | – | – | -26.5% | -36.8% | +216.3% | -12.3% | -39.6% | -5.6% | +26.5% | +54.7% | -44.4% | +23.0% | +2.2% | +37.6% | -35.2% | +30.1% | -68.5% | +55.9% | +94.3% | -43.7% | -16,436.2% | – | -27.8% | -10,612.8% | – | +102.5% | -83.1% | +153.7% | – | |
| – | -3.9% | +13.1% | -77.1% | +44.1% | -14.7% | +56.1% | +3.7% | -6.3% | +36.4% | +6.1% | +6.8% | -0.4% | +1.6% | -5.5% | -8.5% | +15.3% | +12.1% | +2.5% | +25.6% | +0.8% | +40.2% | +23.8% | +3.3% | -19.3% | +7.2% | +40.5% | -11.4% | +0.0% | -3.2% | +3.2% | +18.5% | +1.5% | +0.7% | +7.9% | +10.5% | -29.2% | -38.1% | +33.3% | -12.6% | – | |
| – | -15.4% | -4.2% | +84.8% | -9.8% | -56.8% | +58.3% | -14.1% | -22.6% | +1.2% | -12.4% | +3.6% | +88.5% | -5.4% | -45.5% | +12.3% | -1.5% | +107.8% | -34.6% | +7.0% | -1.7% | +63.1% | +2.7% | -39.2% | +0.2% | +112.8% | -39.6% | +20.4% | -35.3% | +84.7% | -29.5% | -11.9% | +13.4% | -3.7% | +33.3% | -17.3% | +17.5% | -23.1% | +104.5% | -37.9% | – | |
| – | -11.6% | -6.9% | -28.3% | -2.9% | -43.9% | +42.4% | -6.5% | -14.8% | +19.6% | -1.4% | +5.7% | +30.8% | -23.1% | -4.3% | -1.1% | +8.5% | +47.1% | -16.7% | +26.2% | +1.8% | +36.3% | +15.4% | -5.5% | -13.7% | +4.8% | +27.5% | +1.5% | -11.9% | -4.3% | +6.3% | +14.2% | -75.2% | +307.0% | +13.9% | -77.1% | +264.5% | -33.3% | +59.7% | -24.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14.9% | +5.2% | +0.6% | -91.4% | -75.8% | +169.3% | -96.2% | -98.3% | +1,350.0% | +27,806.5% | +7.8% | -23.0% | -14.4% | -22.1% | -56.3% | +1.2% | -90.4% | +3,652.5% | +24.6% | -1.4% | +12.9% | +64.6% | +94.6% | +81.0% | +61.6% | +12.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -428,716.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -461.7% | – | +35.2% | -172.3% | – | – | -494.3% | – | -11,698.7% | – | – | – | – | – | – | +350.1% | -213.5% | – | – | – | – | -202.5% | – | – | – | – | – | – | – | -98.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,197.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.